Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
25 , 18041818 (2011) Perret, J
Additionally, further refinement of the RL feedback mechanism will allow the model to dynamically adjust and improve during the generation process, increasing adaptability and output quality
Fertility is no exception
weight loss at target dose (trial data) ~15% (STEP 1) CV risk reduction labelled Yes (SELECT obesity + CVD) Format Prefilled pen India price (May 2026) 5,66016,400/month (Poviztra co-marketed: 3,9998,999/month) DCGI-approved Yes (20252026) Generic competition in India n/a (innovator) Generic semaglutide 9+ Indian manufacturers Active molecule Semaglutide Receptor activity GLP-1 Primary indication T2D &/or obesity (brand-dependent) Max maintenance dose 0.52.4 mg weekly Avg
